Theravance Biopharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 May 24 | BuyUS$13,117,335 | Madison Avenue Partners, LP | Company | 1,499,124 | US$8.75 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 23,347 | 0.04% |
Individual Insiders | 7,891,791 | 13.5% |
Institutions | 24,260,115 | 41.6% |
Hedge Funds | 26,148,584 | 44.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,511,350 | US$81.2m | 21.4% | 10.83% | |||
7,457,060 | US$71.1m | 0% | 7.8% | |||
7,419,226 | US$70.8m | 0% | 1.53% | |||
4,587,834 | US$43.8m | 0.46% | no data | |||
4,108,318 | US$39.2m | 0% | no data | |||
3,489,262 | US$33.3m | -9.12% | no data | |||
2,760,948 | US$26.3m | 0% | 5.18% | |||
2,168,397 | US$20.7m | 7.97% | 0.01% | |||
1,947,040 | US$18.6m | 15.3% | no data | |||
1,900,000 | US$18.1m | 3.17% | 2.3% | |||
1,390,314 | US$13.3m | -5.5% | no data | |||
1,006,858 | US$9.6m | 5.62% | 0.29% | |||
994,000 | US$9.5m | -6.33% | no data | |||
900,000 | US$8.6m | -54.6% | 0.91% | |||
851,208 | US$8.1m | 23.4% | 0.01% | |||
562,534 | US$5.4m | -2.19% | no data | |||
521,936 | US$5.0m | -6.19% | no data | |||
394,020 | US$3.8m | -3.31% | 0.02% | |||
371,517 | US$3.5m | -19.2% | no data | |||
360,684 | US$3.4m | 29.6% | no data | |||
349,233 | US$3.3m | 5.44% | no data | |||
314,011 | US$3.0m | 0% | no data | |||
287,102 | US$2.7m | 68% | no data | |||
238,636 | US$2.3m | -6.66% | no data | |||
229,768 | US$2.2m | -20% | 0.42% |